Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to ropivacaine for post-cesarean pain
IRCT20221122056579N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine and ropivacaine in postoperative pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain intensity based on visual analog scale, Time to first request for additional analgesic and 4 more. Started Jan 2023; status: completed.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20221122056579N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221122056579N1.